Specimen SS-F-UMA-969 // UMAMI · IFI-U
L-Aspartate Umami II-AG-A
Glycine max
Soybean
Target Trait
1.52×
fold-change
L-aspartate TAS1R1 ligand accumulation index
Technical Specifications
SKU
SS-F-UMA-969
Genomic Edits
4
GC Content
45.2-51.2%
Construct Length
2,855 bp
Promoter System
Tissue-specific 2A11 / CaMV35S
Expression System
Agrobacterium-mediated T-DNA
Host Strain
EHA105
Receptor Target
mGluR1 / TAS1R1-TAS1R3
IFI Score
152
Pathway Edits
- GmAAT2 aspartate aminotransferase isoform 2 overexpression under seed-specific beta-conglycinin promoter for enhanced OAA-to-aspartate transamination in soybean seed
- GmASP4 aspartate 4-hydroxylase RNAi knockdown (60%) to prevent aspartate diversion to beta-amiino acids, preserving free L-aspartate pool as TAS1R1 ligand
- GmASNS asparagine synthetase partial suppression (40%) to reduce glutamine-to-asparagine diversion, freeing aspartate precursor for direct TAS1R1 ligand accumulation
- GmGOT1 glutamate oxaloacetate transaminase isoform 1 overexpression for enhanced aspartate synthesis from OAA across multiple cellular compartments
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Soybean-based umami ingredients and plant-based protein hydrolysates where elevated free L-aspartate contributes as a secondary TAS1R1 agonist alongside glutamate, delivering a broader amino acid umami character.
License
$699 · Tier II License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?